Literature DB >> 3828839

Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action.

R F Lane, C D Blaha.   

Abstract

The effects of chronic haloperidol administration on the basal release of endogenous dopamine (DA) in the intact rat striatum and nucleus accumbens were investigated using in vivo electrochemical techniques. Repeated (21 day) treatment with haloperidol produced marked decreases in the release of DA in both brain regions. Administration of apomorphine to vehicle-treated control animals rapidly reduced DA release, in accord with its inhibitory, hyperpolarizing actions on DA neurons. In contrast, apomorphine reversed the haloperidol-induced reductions in DA release to values that were not significantly different from those measured in control animals. The present study is the first report to demonstrate decreased DA release in response to chronic neuroleptic treatment and to present evidence for induction of depolarization block of DA cell firing as a possible mechanism underlying this effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828839     DOI: 10.1016/0361-9230(87)90042-6

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

1.  Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats.

Authors:  D V Jeste; J B Lohr; M Manley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia.

Authors:  Susan F Sonnenschein; Kathryn M Gill; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-09-18       Impact factor: 7.853

4.  Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations.

Authors:  P A LeDuc; G Mittleman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 5.  Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia.

Authors:  A A Grace
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 6.  Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.

Authors:  Susan F Sonnenschein; Anthony A Grace
Journal:  Neuropharmacology       Date:  2019-05-08       Impact factor: 5.250

7.  Chronic clozapine versus chronic haloperidol treatment: differential effects on electrically evoked dopamine efflux in the rat caudate putamen, but not in the nucleus accumbens.

Authors:  K J Feasey-Truger; C Alzheimer; G ten Bruggencate
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

8.  Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons.

Authors:  H Moore; C L Todd; A A Grace
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

9.  A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal.

Authors:  Ian D Blum; Lei Zhu; Luc Moquin; Maia V Kokoeva; Alain Gratton; Bruno Giros; Kai-Florian Storch
Journal:  Elife       Date:  2014-12-29       Impact factor: 8.140

10.  Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects.

Authors:  Y Kim; P Giusti-Rodriguez; J J Crowley; J Bryois; R J Nonneman; A K Ryan; C R Quackenbush; M D Iglesias-Ussel; P H Lee; W Sun; F P-M de Villena; P F Sullivan
Journal:  Mol Psychiatry       Date:  2017-05-30       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.